Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function

Thomas E. Merchant, Erin N. Kiehna, Larry E. Kun, Raymond K. Mulhern, Chenghong Li, Xiaoping Xiong, Frederick A. Boop, Robert A. Sanford

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Object. A Phase II trial of conformal radiation therapy (CRT) for craniopharyngioma was conducted to determine whether the irradiated volume could be safely reduced to decrease effects on cognitive function. Methods. Between July 1997 and January 2003, 28 pediatric patients (median age 7.3 ± 4.12 years) received CRT in whom doses (54-55.8 Gy) were administered to the gross tumor volume (solid and cystic components) surrounded by a 1-cm clinical target volume margin. Patients were evaluated serially with neuropsychometric testing. Statistical analyses were performed to determine the effect of clinical factors and radiation dosimetry on intelligence quotient (IQ). The median follow-up period was 36.6 months (range 24.4-80 months). The estimated 3-year progression-free survival rate was 90.3 ± 7.3%. Three patients experienced local disease progression. Cognitive outcome for patients was adversely affected by the following factors: age younger than 7.4 years (p = 0.001), an interval between symptoms and diagnosis of more than 73 days (p = 0.06), more extensive surgery (p = 0.014), multiple surgical procedures (p = 0.002), diabetes insipidus (p = 0.02), hydrocephalus at diagnosis (p = 0.009), a cerebrospinal fluid shunt (p = 0.005), shunt revisions (p = 0.01), Ommaya reservoir laterality (p = 0.005), and cyst aspirations (p = 0.02). The percentage of total brain, supratentorial brain, or left temporal lobe volumes receiving a dose in excess of 45 Gy had a significant impact on longitudinal IQ. Conclusions. The use of CRT with a 1-cm margin for clinical target volume results in tumor control equivalent to that achieved using conventionally planned radiation therapy. Surgical morbidity and a volume-receiving dose more than 45 Gy are factors affecting longitudinal IQ after CRT in patients treated for craniopharyngioma.

Original languageEnglish (US)
Pages (from-to)94-102
Number of pages9
JournalJournal of Neurosurgery
Volume104 PEDIATRICS
Issue numberSUPPL. 2
StatePublished - Feb 1 2006

Fingerprint

Radiometry
Craniopharyngioma
Cognition
Radiotherapy
Pediatrics
Intelligence
Cerebrospinal Fluid Shunts
Diabetes Insipidus
Age Factors
Brain
Temporal Lobe
Hydrocephalus
Tumor Burden
Disease-Free Survival
Disease Progression
Cysts
Survival Rate
Morbidity
Neoplasms

Keywords

  • Central nervous system neoplasm
  • Cognition
  • Craniopharyngioma
  • Pediatric neurosurgery
  • Radiotherapy

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)
  • Clinical Neurology

Cite this

Merchant, T. E., Kiehna, E. N., Kun, L. E., Mulhern, R. K., Li, C., Xiong, X., ... Sanford, R. A. (2006). Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. Journal of Neurosurgery, 104 PEDIATRICS(SUPPL. 2), 94-102.

Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. / Merchant, Thomas E.; Kiehna, Erin N.; Kun, Larry E.; Mulhern, Raymond K.; Li, Chenghong; Xiong, Xiaoping; Boop, Frederick A.; Sanford, Robert A.

In: Journal of Neurosurgery, Vol. 104 PEDIATRICS, No. SUPPL. 2, 01.02.2006, p. 94-102.

Research output: Contribution to journalArticle

Merchant, TE, Kiehna, EN, Kun, LE, Mulhern, RK, Li, C, Xiong, X, Boop, FA & Sanford, RA 2006, 'Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function', Journal of Neurosurgery, vol. 104 PEDIATRICS, no. SUPPL. 2, pp. 94-102.
Merchant, Thomas E. ; Kiehna, Erin N. ; Kun, Larry E. ; Mulhern, Raymond K. ; Li, Chenghong ; Xiong, Xiaoping ; Boop, Frederick A. ; Sanford, Robert A. / Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. In: Journal of Neurosurgery. 2006 ; Vol. 104 PEDIATRICS, No. SUPPL. 2. pp. 94-102.
@article{b34cede029bb4badb5fdf8bbb0df0165,
title = "Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function",
abstract = "Object. A Phase II trial of conformal radiation therapy (CRT) for craniopharyngioma was conducted to determine whether the irradiated volume could be safely reduced to decrease effects on cognitive function. Methods. Between July 1997 and January 2003, 28 pediatric patients (median age 7.3 ± 4.12 years) received CRT in whom doses (54-55.8 Gy) were administered to the gross tumor volume (solid and cystic components) surrounded by a 1-cm clinical target volume margin. Patients were evaluated serially with neuropsychometric testing. Statistical analyses were performed to determine the effect of clinical factors and radiation dosimetry on intelligence quotient (IQ). The median follow-up period was 36.6 months (range 24.4-80 months). The estimated 3-year progression-free survival rate was 90.3 ± 7.3{\%}. Three patients experienced local disease progression. Cognitive outcome for patients was adversely affected by the following factors: age younger than 7.4 years (p = 0.001), an interval between symptoms and diagnosis of more than 73 days (p = 0.06), more extensive surgery (p = 0.014), multiple surgical procedures (p = 0.002), diabetes insipidus (p = 0.02), hydrocephalus at diagnosis (p = 0.009), a cerebrospinal fluid shunt (p = 0.005), shunt revisions (p = 0.01), Ommaya reservoir laterality (p = 0.005), and cyst aspirations (p = 0.02). The percentage of total brain, supratentorial brain, or left temporal lobe volumes receiving a dose in excess of 45 Gy had a significant impact on longitudinal IQ. Conclusions. The use of CRT with a 1-cm margin for clinical target volume results in tumor control equivalent to that achieved using conventionally planned radiation therapy. Surgical morbidity and a volume-receiving dose more than 45 Gy are factors affecting longitudinal IQ after CRT in patients treated for craniopharyngioma.",
keywords = "Central nervous system neoplasm, Cognition, Craniopharyngioma, Pediatric neurosurgery, Radiotherapy",
author = "Merchant, {Thomas E.} and Kiehna, {Erin N.} and Kun, {Larry E.} and Mulhern, {Raymond K.} and Chenghong Li and Xiaoping Xiong and Boop, {Frederick A.} and Sanford, {Robert A.}",
year = "2006",
month = "2",
day = "1",
language = "English (US)",
volume = "104 PEDIATRICS",
pages = "94--102",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function

AU - Merchant, Thomas E.

AU - Kiehna, Erin N.

AU - Kun, Larry E.

AU - Mulhern, Raymond K.

AU - Li, Chenghong

AU - Xiong, Xiaoping

AU - Boop, Frederick A.

AU - Sanford, Robert A.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Object. A Phase II trial of conformal radiation therapy (CRT) for craniopharyngioma was conducted to determine whether the irradiated volume could be safely reduced to decrease effects on cognitive function. Methods. Between July 1997 and January 2003, 28 pediatric patients (median age 7.3 ± 4.12 years) received CRT in whom doses (54-55.8 Gy) were administered to the gross tumor volume (solid and cystic components) surrounded by a 1-cm clinical target volume margin. Patients were evaluated serially with neuropsychometric testing. Statistical analyses were performed to determine the effect of clinical factors and radiation dosimetry on intelligence quotient (IQ). The median follow-up period was 36.6 months (range 24.4-80 months). The estimated 3-year progression-free survival rate was 90.3 ± 7.3%. Three patients experienced local disease progression. Cognitive outcome for patients was adversely affected by the following factors: age younger than 7.4 years (p = 0.001), an interval between symptoms and diagnosis of more than 73 days (p = 0.06), more extensive surgery (p = 0.014), multiple surgical procedures (p = 0.002), diabetes insipidus (p = 0.02), hydrocephalus at diagnosis (p = 0.009), a cerebrospinal fluid shunt (p = 0.005), shunt revisions (p = 0.01), Ommaya reservoir laterality (p = 0.005), and cyst aspirations (p = 0.02). The percentage of total brain, supratentorial brain, or left temporal lobe volumes receiving a dose in excess of 45 Gy had a significant impact on longitudinal IQ. Conclusions. The use of CRT with a 1-cm margin for clinical target volume results in tumor control equivalent to that achieved using conventionally planned radiation therapy. Surgical morbidity and a volume-receiving dose more than 45 Gy are factors affecting longitudinal IQ after CRT in patients treated for craniopharyngioma.

AB - Object. A Phase II trial of conformal radiation therapy (CRT) for craniopharyngioma was conducted to determine whether the irradiated volume could be safely reduced to decrease effects on cognitive function. Methods. Between July 1997 and January 2003, 28 pediatric patients (median age 7.3 ± 4.12 years) received CRT in whom doses (54-55.8 Gy) were administered to the gross tumor volume (solid and cystic components) surrounded by a 1-cm clinical target volume margin. Patients were evaluated serially with neuropsychometric testing. Statistical analyses were performed to determine the effect of clinical factors and radiation dosimetry on intelligence quotient (IQ). The median follow-up period was 36.6 months (range 24.4-80 months). The estimated 3-year progression-free survival rate was 90.3 ± 7.3%. Three patients experienced local disease progression. Cognitive outcome for patients was adversely affected by the following factors: age younger than 7.4 years (p = 0.001), an interval between symptoms and diagnosis of more than 73 days (p = 0.06), more extensive surgery (p = 0.014), multiple surgical procedures (p = 0.002), diabetes insipidus (p = 0.02), hydrocephalus at diagnosis (p = 0.009), a cerebrospinal fluid shunt (p = 0.005), shunt revisions (p = 0.01), Ommaya reservoir laterality (p = 0.005), and cyst aspirations (p = 0.02). The percentage of total brain, supratentorial brain, or left temporal lobe volumes receiving a dose in excess of 45 Gy had a significant impact on longitudinal IQ. Conclusions. The use of CRT with a 1-cm margin for clinical target volume results in tumor control equivalent to that achieved using conventionally planned radiation therapy. Surgical morbidity and a volume-receiving dose more than 45 Gy are factors affecting longitudinal IQ after CRT in patients treated for craniopharyngioma.

KW - Central nervous system neoplasm

KW - Cognition

KW - Craniopharyngioma

KW - Pediatric neurosurgery

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=33644887442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644887442&partnerID=8YFLogxK

M3 - Article

C2 - 16506496

AN - SCOPUS:33644887442

VL - 104 PEDIATRICS

SP - 94

EP - 102

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - SUPPL. 2

ER -